Sino Biopharmaceutical (OTCMKTS:SBMFF – Get Free Report) gapped down prior to trading on Monday . The stock had previously closed at $0.7602, but opened at $0.6923. Sino Biopharmaceutical shares last traded at $0.6923, with a volume of 7,406 shares trading hands.
Sino Biopharmaceutical Stock Down 0.5%
The firm’s 50 day simple moving average is $0.79 and its 200-day simple moving average is $0.84.
Sino Biopharmaceutical Company Profile
Sino Biopharmaceutical Limited (OTCMKTS: SBMFF) is a Hong Kong–incorporated investment holding company principally engaged in the pharmaceutical sector. Founded in 2000 and listed on the Hong Kong Stock Exchange in 2006, the company has developed an integrated business model that spans research and development, manufacturing and commercialization of healthcare products. Through its subsidiaries, Sino Biopharmaceutical focuses on enhancing China’s domestic pharmaceutical infrastructure while expanding its footprint across key therapeutic areas.
The company’s product portfolio is organized into three core segments: infusion solutions, small-molecule synthetic pharmaceuticals and innovative biologics.
Featured Stories
- Five stocks we like better than Sino Biopharmaceutical
- Before the Moon Base Gets Built, These 4 Companies Win
- Industrial Buybacks: Top Homebuilding Supplier Leads Buyback Increases
- 3 Stocks That Win If Inflation Surprises to the Downside
- MercadoLibre Boldly Invests in Growth: Discount Deepens
Receive News & Ratings for Sino Biopharmaceutical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sino Biopharmaceutical and related companies with MarketBeat.com's FREE daily email newsletter.
